Allergan, Inc. : AGN

All AGN Articles

189 Articles

Jon C. Ogg | Jun 3, 2014 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Allergan, Broadcom, NBG, Devon, NOV, Kroger and More

These are the top Wall Street analyst upgrades, downgrades and initiations seen on Tuesday, June 3, 2014. They include Apple,…

Paul Ausick | May 30, 2014 at 3:05 PM EDT

Valeant Offers Even More for Botox-Maker Allergan

ThinkstockCanada-based Valeant Pharmaceuticals Inc. (NYSE: VRX) has raised its offer for Allergan Inc. (NYSE: AGN) for the second time this…

Jon C. Ogg | May 13, 2014 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Rackspace, Baker Hughes, Time Warner and More

These are the top Wall Street analyst upgrades, downgrades and initiations seen on Tuesday, May 13, 2014. They include Allergan,…

Jon C. Ogg | May 12, 2014 at 12:35 PM EDT

Should Allergan Shareholders Be Worried?

Allergan has been a great company, and it can still be one in the future. The question is whether this…

Jon C. Ogg | Apr 28, 2014 at 8:15 AM EDT

Top Analyst Upgrades and Downgrades: AIG, BlackBerry, CenturyLink, Deckers Outdoor, Whole Foods and More

These are the top analyst upgrades, downgrades, and initiations seen from Wall Street research firms on Monday. April 28, 2014.…

Jon C. Ogg | Apr 23, 2014 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Galmed, GM, Sirius XM, SunPower and More

These are the top Wall Street analyst upgrades, downgrades and initiations seen on Wednesday, April 23, 2014. They include Allergan,…

Trey Thoelcke | Mar 4, 2014 at 8:50 AM EST

Merrill Lynch’s Top Health Care Stocks to Buy Now

Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…

Trey Thoelcke | Feb 7, 2014 at 8:45 AM EST

Credit Suisse Adds 10 New Stocks to Buy to Its Top Picks List

The equity strategists at Credit Suisse have used the sell-off to make some massive changes in their Top Picks list.…

Jon C. Ogg | Feb 4, 2014 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014.…

Jon C. Ogg | Jan 27, 2014 at 11:05 AM EST

Analyst Team Sees Strong Biotech Buyout Market in 2014

Analysts at at Merrill Lynch see 2014 as a promising year for biotech mergers and acquisitions. A new research report…

Lee Jackson | Nov 21, 2013 at 8:55 AM EST

Merrill Lynch Sees Seven Stocks to Buy for Breakout Patterns

ThinkstockMany fundamental analysts will tell you the chart followers are nothing more than people reporting after-the-fact data. The reality on…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Jul 24, 2013 at 8:30 AM EDT

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

ThinkstockTypically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that…

Trey Thoelcke | Jul 3, 2013 at 8:10 AM EDT

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

When we screen stocks at the Wall Street firms we cover, we always are anxious to provide our readers with…

Paul Ausick | Jun 25, 2013 at 11:20 AM EDT

Can Allergan Bounce Again?

ThinkstockPharmaceutical giant Allergan Inc. (NYSE: AGN) saw its stock climb to an all-time high of more than $116 a share…

1 … 7 8 9 10 11 … 13

Allergan, Inc. : AGN

All AGN Articles

Top Analyst Upgrades and Downgrades: Apple, Allergan, Broadcom, NBG, Devon, NOV, Kroger and More

Valeant Offers Even More for Botox-Maker Allergan

Top Analyst Upgrades and Downgrades: Allergan, Rackspace, Baker Hughes, Time Warner and More

Should Allergan Shareholders Be Worried?

Top Analyst Upgrades and Downgrades: AIG, BlackBerry, CenturyLink, Deckers Outdoor, Whole Foods and More

Top Analyst Upgrades and Downgrades: Allergan, Galmed, GM, Sirius XM, SunPower and More

Merrill Lynch’s Top Health Care Stocks to Buy Now

Credit Suisse Adds 10 New Stocks to Buy to Its Top Picks List

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Analyst Team Sees Strong Biotech Buyout Market in 2014

Merrill Lynch Sees Seven Stocks to Buy for Breakout Patterns

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

Can Allergan Bounce Again?

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Allergan, Inc. : AGN

All AGN Articles

Top Analyst Upgrades and Downgrades: Apple, Allergan, Broadcom, NBG, Devon, NOV, Kroger and More

Valeant Offers Even More for Botox-Maker Allergan

Top Analyst Upgrades and Downgrades: Allergan, Rackspace, Baker Hughes, Time Warner and More

Should Allergan Shareholders Be Worried?

Top Analyst Upgrades and Downgrades: AIG, BlackBerry, CenturyLink, Deckers Outdoor, Whole Foods and More

Top Analyst Upgrades and Downgrades: Allergan, Galmed, GM, Sirius XM, SunPower and More

Merrill Lynch’s Top Health Care Stocks to Buy Now

Credit Suisse Adds 10 New Stocks to Buy to Its Top Picks List

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Analyst Team Sees Strong Biotech Buyout Market in 2014

Merrill Lynch Sees Seven Stocks to Buy for Breakout Patterns

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

Can Allergan Bounce Again?

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Featured Reads

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients